Effects and Mechanisms of Glucocorticoid Combined with IFN-γ on Pulmonary Fibrosis in Mice
Hai Chun-xu
Abstract
Hai Chun-xu
Abstract
BACKGROUND AND AIM:To explore therapeutic effects of IFN-γ combined with glucocorticoid on pulmonary fibrosis in mice.MATERIALS AND METHODS: Mice were divided into five random groups: negative control(NS)group;model(bleomycine,BLM)group;dexamethasone(DXM) treatment group;IFN-γ treatment group;DXM combined IFN-γ treatment group.To establish the pulmonary fibrosis model,the last four groups received BLM intratracheally at a dose of 3 mg/kg,NS group received NS by the same way.From 1st day after BLM treatment,DXM group and combined group were treated with 20 mg/kg DXM subcutaneously.And from 15th day after BLM treatment,IFN-γ and combined groups were treated with IFN-γ 0.01 μg/g subcutaneously.After the different treatments,animals were killed at 22nd day.The pathological changes were examined,hydroxyproline content(Hyp)was assayed by acid hydrolyzation,TNF-α expression was shown by IHC,and GSH/GSSG ratio,MDA content as well as T-SOD activity were determined by fluorimetry.RESULTS: Pathological score and Hyp content of combined group were both significantly lower than BLM and individual treatment groups(P0.05).TNF-α expression was highest in IFN-γ treatment group,while that of combined group was between the BLM and DXM treatment groups.Compared with BLM and individual treatment groups,GSH/GSSG ratio was higher but MDA content was lower in combined group(P0.05).T-SOD activities were not significantly different among groups(P0.05).CONCLUSION: The results indicated the effects of DXM combined withIFN-γ was better than their individual effect.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
BACKGROUND AND AIM:To explore therapeutic effects of IFN-γ combined with glucocorticoid on pulmonary fibrosis in mice.MATERIALS AND METHODS: Mice were divided into five random groups: negative control(NS)group;model(bleomycine,BLM)group;dexamethasone(DXM) treatment group;IFN-γ treatment group;DXM combined IFN-γ treatment group.To establish the pulmonary fibrosis model,the last four groups received BLM intratracheally at a dose of 3 mg/kg,NS group received NS by the same way.From 1st day after BLM treatment,DXM group and combined group were treated with 20 mg/kg DXM subcutaneously.And from 15th day after BLM treatment,IFN-γ and combined groups were treated with IFN-γ 0.01 μg/g subcutaneously.After the different treatments,animals were killed at 22nd day.The pathological changes were examined,hydroxyproline content(Hyp)was assayed by acid hydrolyzation,TNF-α expression was shown by IHC,and GSH/GSSG ratio,MDA content as well as T-SOD activity were determined by fluorimetry.RESULTS: Pathological score and Hyp content of combined group were both significantly lower than BLM and individual treatment groups(P0.05).TNF-α expression was highest in IFN-γ treatment group,while that of combined group was between the BLM and DXM treatment groups.Compared with BLM and individual treatment groups,GSH/GSSG ratio was higher but MDA content was lower in combined group(P0.05).T-SOD activities were not significantly different among groups(P0.05).CONCLUSION: The results indicated the effects of DXM combined withIFN-γ was better than their individual effect.
Key concepts: Hydroxyproline, Glucocorticoid, Dexamethasone, Pulmonary fibrosis, Fibrosis, Glutathione, Internal medicine, Medicine